Online citations, reference lists, and bibliographies.
← Back to Search

Tomotherapy After Pleurectomy/Decortication Or Biopsy For Malignant Pleural Mesothelioma Allows The Delivery Of High Dose Of Radiation In Patients With Intact Lung

E. Minatel, M. Trovò, J. Polesel, I. A. Rumeileh, T. Baresic, A. Bearz, A. Del Conte, G. Franchin, C. Gobitti, A. Drigo, A. Dassie, V. Pagan, M. Trovò
Published 2012 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Introduction: This study aimed to assess the safety of high doses of radiation delivered with tomotherapy to the intact lung after radical pleurectomy/decortication or biopsy for malignant pleural mesothelioma (MPM). Methods: Twenty-eight patients were enrolled in this prospective study and underwent adjuvant or definitive tomotherapy after radical pleurectomy/decortication (n = 20) or pleural biopsy (n = 8) for MPM. The dose prescribed to the planning target volume, defined as the entire hemithorax, including chest-wall incisions and drain sites and excluding the intact lung, was 50 Gy delivered in 25 fractions. All patients underwent fluorodeoxyglucose-positron emission tomography for staging after surgery. Any fluorodeoxyglucose-avid areas or regions of particular concern for residual disease were given a simultaneous boost of radiotherapy to 60 Gy. Specific lung dosimetric parameters were reported. Toxicity was graded using the modified Common Toxicity Criteria version 3.0. Results: The median follow-up was of 19 months (range, 6–29 months). Five patients (17.8%) experienced severe respiratory symptoms corresponding to grade 2 pneumonitis in three cases, and grade 3 pneumonitis in two cases. No fatal respiratory toxicity was reported. Controlateral lung V5 was strongly correlated with the risk of pneumonitis. Patients who developed grade 2 and 3 pneumonitis had a higher controlateral lung V5 (mean V5=32%) than those without pneumonitis (mean V5=17%) (p=0.002). Other two grade 3 toxicities were registered: one severe pain to the chest wall, and one severe thrombocytopenia. Conclusions: Tomotherapy allows the safe delivery of high dose of radiation to the hemithorax of MPM patients with intact lung.
This paper references
10.1016/j.ijrobp.2007.11.011
Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience.
E. Miles (2008)
10.1016/S0360-3016(02)04150-0
Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation.
K. Forster (2003)
10.1016/J.IJROBP.2005.03.041
Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma.
V. Gupta (2005)
10.1016/S0360-3016(98)00196-5
Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients.
S. L. Kwa (1998)
10.1093/annonc/mdp271
Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma.
A. Avigdor (2010)
10.1016/S0360-3016(99)00183-2
Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)
M. Graham (1999)
10.1016/J.IJROBP.2005.03.026
Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study.
E. Yorke (2005)
10.1118/1.596958
Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy.
T. Mackie (1993)
10.1016/j.ijrobp.2011.09.027
Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma.
K. Rosenzweig (2012)
10.1016/J.IJROBP.2006.03.012
Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.
A. Allen (2006)
10.1093/annonc/mdq173
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
R. Stahel (2010)
[Surgery for malignant pleural mesothelioma].
R. Giudicelli (2004)
Pleural intensitymodulated radiotherapy for malignant pleural mesothelioma
KE Rosenzweig (2012)
10.1016/J.IJROBP.2007.03.011
Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.
D. Rice (2007)



This paper is referenced by
10.1136/thoraxjnl-2017-211321
British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma
I. Woolhouse (2018)
10.1007/s00066-019-01458-1
Tomotherapy in malignant mesothelioma: a planning study to establish dose constraints
C. Leitzen (2019)
10.21037/atm.2017.06.25
Malignant pleural mesothelioma: adjuvant therapy with radiation therapy.
K. Rosenzweig (2017)
10.1016/j.radonc.2017.08.003
The role of radical radiotherapy in the management of malignant pleural mesothelioma: A systematic review.
M. Ashton (2017)
10.1007/s00066-017-1108-y
Does selective pleural irradiation of malignant pleural mesothelioma allow radiation dose escalation?
A. Botticella (2017)
10.1016/j.cllc.2018.08.019
Moderately Hypofractionated Helical IMRT, FDG–PET/CT‐guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs
A. Fodor (2019)
10.1016/j.ijrobp.2017.04.025
Heart Dosimetry is Correlated With Risk of Radiation Pneumonitis After Lung-Sparing Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma.
E. Yorke (2017)
10.1097/JTO.0b013e318286c743
Tomotherapy after pleurectomy or decortication or biopsy for malignant pleural mesothelioma.
Servet Boeluekbas (2013)
10.1053/j.semtcvs.2013.10.004
Current readings: improvements in intensity-modulated radiation therapy for malignant pleural mesothelioma.
K. Rosenzweig (2013)
10.1016/j.canrad.2016.09.009
Radiation therapy for malignant pleural mesothelioma.
K. Rosenzweig (2017)
10.1016/j.rpor.2017.07.006
Malignant pleural mesothelioma - Pleural cavity irradiation after decortication with helical tomotherapy.
S. Harrabi (2017)
10.21037/jxym.2018.07.02
Chest tumors: current trends of clinical practice
Patricia Tai (2018)
10.1016/J.ARBRES.2014.06.005
Diagnóstico y tratamiento del mesotelioma pleural maligno
Francisco Rodríguez Panadero (2015)
10.1016/J.THORSURG.2020.08.006
Radiation Therapy for Malignant Pleural Mesothelioma.
K. Rosenzweig (2020)
10.1080/0284186X.2016.1234066
Optimal gross tumor volume definition in lung-sparing intensity modulated radiotherapy for pleural mesothelioma: an in silico study
A. Botticella (2016)
10.1684/BDC.2013.1857
Mésothéliomes malins pleuraux : le point en 2013
Karine Campbell (2013)
Volumetric-modulated arc therapy for malignant pleural mesothelioma after pleurectomy / decortication
V. Dumane (2016)
Patient-Derived Organotypic Tumor Spheroids Facilitate Precision Medicine Advances in Therapeutic Screening for Malignant Pleural Mesothelioma
Dalia Larios Chavez (2019)
10.1016/J.ARBR.2015.02.009
Diagnosis and Treatment of Malignant Pleural Mesothelioma
Francisco Rodríguez Panadero (2015)
10.1016/j.ijrobp.2015.06.029
Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors.
E. Minatel (2015)
Mécanismes cérébraux de la régulation de la douleur : perception de la douleur et hypoalgésie induite psychologiquement
Audrey-Anne Dubé (2015)
10.1016/S1877-1203(13)70385-9
Traitements médicaux du mésothéliome
Sophie M. Jaillard (2013)
10.2217/LMT.15.16
Multimodality therapy for malignant pleural mesothelioma: surgery plus chemoradiotherapy?
A. Wolf (2015)
10.1016/j.prro.2020.06.003
RapidPlan for Knowledge-Based Planning of Malignant Pleural Mesothelioma.
V. Dumane (2020)
10.1586/17476348.2013.838016
Advances in the management of pleural disease
J. Corcoran (2013)
10.1097/JTO.0000000000000099
Failure Patterns Relative to Radiation Treatment Fields for Stage II–IV Thymoma
A. Rimner (2014)
10.1016/j.arbres.2014.06.005
Diagnosis and treatment of malignant pleural mesothelioma.
F. Rodríguez Panadero (2015)
10.21037/tlcr.2018.04.07
Proton beam therapy for malignant pleural mesothelioma.
S. Badiyan (2018)
10.1016/j.lungcan.2013.10.013
Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up.
E. Minatel (2014)
10.1016/j.prro.2020.05.004
Consensus Statement on Proton Therapy in Mesothelioma.
J. Zeng (2020)
10.1155/2019/4568958
Dosimetric Comparison of Lung-Sparing Radiation Therapy between Volumetric Arc Therapy and Helical Tomotherapy for Unresectable Malignant Pleural Mesothelioma
B. Pehlivan (2019)
10.1016/j.prro.2018.12.008
Dosimetric Correlates of Pulmonary Toxicity in Patients with Malignant Pleural Mesothelioma Receiving Radiation Therapy to the Intact Lungs.
M. Thompson (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar